Avinger
Avinger
AVGR
NASDAQ
0.57
USD
21.28%
About
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients.
Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV)..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 93.4K |
| Three Month Average Volume | 1.1M |
| High Low | |
| Fifty-Two Week High | 14 USD |
| Fifty-Two Week Low | 1 USD |
| Fifty-Two Week High Date | 20 Sep 2023 |
| Fifty-Two Week Low Date | 28 Aug 2024 |
| Price and Volume | |
| Current Price | 1.11 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -24.95% |
| Thirteen Week Relative Price Change | -51.65% |
| Twenty-Six Week Relative Price Change | -73.08% |
| Fifty-Two Week Relative Price Change | -86.91% |
| Year-to-Date Relative Price Change | -65.41% |
| Price Change | |
| One Day Price Change | 0.91% |
| Thirteen Week Price Change | -48.25% |
| Twenty-Six Week Price Change | -70.40% |
| Five Day Price Change | -13.95% |
| Fifty-Two Week Price Change | -83.60% |
| Year-to-Date Price Change | -59.04% |
| Month-to-Date Price Change | -26.00% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | -4.84558 USD |
| Book Value Per Share (Most Recent Quarter) | 4.04554 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | -4.84558 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 4.04554 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -13.77237 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 9.73537 USD |
| Revenue Per Share (Trailing Twelve Months) | 5.83124 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -23.30789 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -12.12894 USD |
| Normalized (Last Fiscal Year) | -23.30789 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -23.30789 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -12.12894 USD |
| Including Extraordinary Items (Last Fiscal Year) | -23.30789 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -12.12894 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 4.12132 USD |
| Cash Per Share (Most Recent Quarter) | 4.595 USD |
| Cash Flow Per Share (Last Fiscal Year) | -22.9402 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -15.19937 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -11.95369 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -180 |
| Cash Flow Revenue (Trailing Twelve Months) | -205 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -260.86% |
| Pretax Margin (Last Fiscal Year) | -239.41% |
| Pretax Margin (5 Year) | -208.91% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 26.18% |
| Gross Margin (Trailing Twelve Months) | 19.96% |
| Gross Margin (5 Year) | 30.87% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -217.39% |
| Operating Margin (Trailing Twelve Months) | -240.46% |
| Operating Margin (5 Year) | -193.77% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -239.41% |
| Net Profit Margin (Trailing Twelve Months) | -260.86% |
| Net Profit Margin (5 Year) | -208.91% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -9.51% |
| Revenue Growth (3 Year) | -0.67% |
| Revenue Change (Trailing Twelve Months) | -9.20% |
| Revenue Per Share Growth | -66.25% |
| Revenue Growth (5 Year) | -4.41% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -24.21% |
| Total Debt (5 Year) | 13.81% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 68.19% |
| EPS Change (Trailing Twelve Months) | 70.81% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | 0 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -4,762,000 |
| Net Debt (Last Fiscal Year) | 9.0M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | -100,000 |
| Price to Book (Most Recent Quarter) | 0 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | -100,000 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 0 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -14,440,000 |
| Free Cash Flow (Trailing Twelve Months) | -15,229,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -10 |
| Net Interest Coverage (Trailing Twelve Months) | -12 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | -100,000 |
| Total Debt to Equity (Most Recent Quarter) | 52 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -96.51% |
| Return on Assets (Trailing Twelve Months) | -113.20% |
| Return on Assets (5 Year) | -70.93% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -99,999.99% |
| Return on Equity (Trailing Twelve Months) | -2,637.66% |
| Return on Equity (5 Year) | -318.74% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -5,095.97% |
| Return on Investment (Trailing Twelve Months) | -1,387.68% |
| Return on Investment (5 Year) | -131.57% |